ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,813,887 | -9.7% | 67,506 | +19.9% | 0.01% | -12.5% |
| Q2 2023 | $2,008,479 | +40.4% | 56,323 | 0.0% | 0.01% | +33.3% |
| Q1 2023 | $1,430,604 | +58675.8% | 56,323 | -6.1% | 0.01% | -45.5% |
| Q4 2022 | $2,434 | +5.2% | 60,000 | -14.3% | 0.01% | 0.0% |
| Q3 2022 | $2,314 | -100.0% | 70,000 | -36.0% | 0.01% | -68.6% |
| Q2 2021 | $9,065,000 | +364.2% | 109,453 | +271.6% | 0.04% | +337.5% |
| Q1 2021 | $1,953,000 | -77.9% | 29,453 | -74.4% | 0.01% | -78.4% |
| Q4 2020 | $8,840,000 | +596.1% | 115,205 | +161.1% | 0.04% | +428.6% |
| Q1 2020 | $1,270,000 | -33.3% | 44,126 | +47.1% | 0.01% | -12.5% |
| Q4 2019 | $1,903,000 | -3.9% | 30,000 | -57.3% | 0.01% | -11.1% |
| Q3 2019 | $1,981,000 | +16.6% | 70,282 | +9.6% | 0.01% | +12.5% |
| Q2 2019 | $1,699,000 | – | 64,127 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |